Literature DB >> 20093779

A promoter in the novel exon of hPPARgamma directs the circadian expression of PPARgamma.

Seiichiro Takahashi1, Ikuo Inoue, Yoshihiro Nakajima, Makoto Seo, Takanari Nakano, Fang Yang, Megumi Kumagai, Tsugikazu Komoda, Takuya Awata, Masaaki Ikeda, Shigehiro Katayama.   

Abstract

AIM: PPARgamma (peroxisome proliferator-activated receptor gamma) is a member of the nuclear receptor superfamily of ligand-activated transcription factors that regulate the expression of genes associated with lipid metabolism. Herein, we show that expression levels of the novel PPARgamma transcript exhibit circadian oscillation. To study the mechanisms controlling PPARgamma expression, a novel PPARgamma gene promoter was cloned and characterized.
METHODS: We analyzed the novel PPARgamma promoter by luciferase reporter assays and gel shift analysis.
RESULTS: Surprisingly, it was not an intron but rather the novel first exon of PPARgamma that was found to have functional minimal promoter activity. Luciferase reporter assays and gel shift assays revealed that the novel first exon is essential for novel PPARgamma promoter activation and that DBP (albumin gene D-site binding protein) and E4BP4 (E4 promoter A binding protein 4) bind directly to D-sites in the novel first exon.
CONCLUSION: Our results demonstrate that the PAR-bZIP (bZIP, basic leucine zipper) family and E4BP4 are the main regulatory factors involved in oscillation of novel PPARgamma expression. This regulatory mechanism clearly differs from that of the circadian expression of PPARalpha.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093779     DOI: 10.5551/jat.2410

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  18 in total

1.  A wheel of time: the circadian clock, nuclear receptors, and physiology.

Authors:  Xiaoyong Yang
Journal:  Genes Dev       Date:  2010-04-15       Impact factor: 11.361

2.  R-α-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles.

Authors:  Liam A Finlay; Alex J Michels; Judy A Butler; Eric J Smith; Jeffrey S Monette; Régis F Moreau; Shay Kate Petersen; Balz Frei; Tory M Hagen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-02       Impact factor: 3.619

3.  Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding.

Authors:  Xin Tong; Marina Muchnik; Zheng Chen; Manish Patel; Nan Wu; Shree Joshi; Liangyou Rui; Mitchell A Lazar; Lei Yin
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

4.  Importance of RNA analysis in interpretation of reporter gene expression data.

Authors:  Victoria P Belancio
Journal:  Anal Biochem       Date:  2011-05-30       Impact factor: 3.365

5.  Recruitment of histone methyltransferase G9a mediates transcriptional repression of Fgf21 gene by E4BP4 protein.

Authors:  Xin Tong; Deqiang Zhang; Katie Buelow; Anirvan Guha; Blake Arthurs; Hugh J M Brady; Lei Yin
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

6.  RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice.

Authors:  Denuja Karunakaran; Adam W Turner; Anne-Claire Duchez; Sebastien Soubeyrand; Adil Rasheed; David Smyth; David P Cook; Majid Nikpay; Joshua W Kandiah; Calvin Pan; Michele Geoffrion; Richard Lee; Ludovic Boytard; Hailey Wyatt; My-Anh Nguyen; Paulina Lau; Markku Laakso; Bhama Ramkhelawon; Marcus Alvarez; Kirsi H Pietiläinen; Päivi Pajukanta; Barbara C Vanderhyden; Peter Liu; Scott B Berger; Peter J Gough; John Bertin; Mary-Ellen Harper; Aldons J Lusis; Ruth McPherson; Katey J Rayner
Journal:  Nat Metab       Date:  2020-09-28

Review 7.  Molecular clocks in pharmacology.

Authors:  Erik S Musiek; Garret A Fitzgerald
Journal:  Handb Exp Pharmacol       Date:  2013

Review 8.  Nuclear receptors and AMPK: resetting metabolism.

Authors:  W Fan; M Downes; A Atkins; R Yu; R M Evans
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2012-03-12

Review 9.  PPAR gamma, bioactive lipids, and cancer progression.

Authors:  Gregory T Robbins; Daotai Nie
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

10.  Time-Qualified Patterns of Variation of PPARγ, DNMT1, and DNMT3B Expression in Pancreatic Cancer Cell Lines.

Authors:  Valerio Pazienza; Francesca Tavano; Massimo Francavilla; Andrea Fontana; Fabio Pellegrini; Giorgia Benegiamo; Vincenzo Corbo; Fabio Francesco di Mola; Pierluigi Di Sebastiano; Angelo Andriulli; Gianluigi Mazzoccoli
Journal:  PPAR Res       Date:  2012-08-26       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.